List of Tables
Table 1. Global Treatment for Accelerated-Phase CML Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Treatment for Accelerated-Phase CML Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Treatment for Accelerated-Phase CML Market Competitive Situation by Manufacturers in 2025
Table 4. Global Treatment for Accelerated-Phase CML Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Treatment for Accelerated-Phase CML Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Treatment for Accelerated-Phase CML Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Treatment for Accelerated-Phase CML Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Treatment for Accelerated-Phase CML Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Treatment for Accelerated-Phase CML, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Treatment for Accelerated-Phase CML, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Treatment for Accelerated-Phase CML, Product Types and Applications
Table 12. Global Key Manufacturers of Treatment for Accelerated-Phase CML, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment for Accelerated-Phase CML Companies by Tier (Tier 1, Tier 2, Tier 3), based on Treatment for Accelerated-Phase CML Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment for Accelerated-Phase CML Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Treatment for Accelerated-Phase CML Sales by Region (K Units), 2021–2026
Table 18. Global Treatment for Accelerated-Phase CML Sales Market Share by Region (2021–2026)
Table 19. Global Treatment for Accelerated-Phase CML Sales by Region (K Units), 2027–2032
Table 20. Global Treatment for Accelerated-Phase CML Sales Market Share by Region (2027–2032)
Table 21. Global Treatment for Accelerated-Phase CML Revenue by Region (US$ Million), 2021–2026
Table 22. Global Treatment for Accelerated-Phase CML Revenue Market Share by Region (2021–2026)
Table 23. Global Treatment for Accelerated-Phase CML Revenue by Region (US$ Million), 2027–2032
Table 24. Global Treatment for Accelerated-Phase CML Revenue Market Share by Region (2027–2032)
Table 25. North America Treatment for Accelerated-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Treatment for Accelerated-Phase CML Sales by Country (K Units), 2021–2026
Table 27. North America Treatment for Accelerated-Phase CML Sales by Country (K Units), 2027–2032
Table 28. North America Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 29. North America Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Treatment for Accelerated-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Treatment for Accelerated-Phase CML Sales by Country (K Units), 2021–2026
Table 32. Europe Treatment for Accelerated-Phase CML Sales by Country (K Units), 2027–2032
Table 33. Europe Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Treatment for Accelerated-Phase CML Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Treatment for Accelerated-Phase CML Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Treatment for Accelerated-Phase CML Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Treatment for Accelerated-Phase CML Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Treatment for Accelerated-Phase CML Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Treatment for Accelerated-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Treatment for Accelerated-Phase CML Sales by Country (K Units), 2021–2026
Table 42. Latin America Treatment for Accelerated-Phase CML Sales by Country (K Units), 2027–2032
Table 43. Latin America Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Treatment for Accelerated-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Treatment for Accelerated-Phase CML Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Treatment for Accelerated-Phase CML Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Treatment for Accelerated-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 50. Global Treatment for Accelerated-Phase CML Sales (K Units) by Type (2021–2026)
Table 51. Global Treatment for Accelerated-Phase CML Sales (K Units) by Type (2027–2032)
Table 52. Global Treatment for Accelerated-Phase CML Sales Market Share by Type (2021–2026)
Table 53. Global Treatment for Accelerated-Phase CML Sales Market Share by Type (2027–2032)
Table 54. Global Treatment for Accelerated-Phase CML Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Treatment for Accelerated-Phase CML Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Treatment for Accelerated-Phase CML Revenue Market Share by Type (2021–2026)
Table 57. Global Treatment for Accelerated-Phase CML Revenue Market Share by Type (2027–2032)
Table 58. Global Treatment for Accelerated-Phase CML Price (US$/Unit) by Type (2021–2026)
Table 59. Global Treatment for Accelerated-Phase CML Price (US$/Unit) by Type (2027–2032)
Table 60. Global Treatment for Accelerated-Phase CML Sales (K Units) by Application (2021–2026)
Table 61. Global Treatment for Accelerated-Phase CML Sales (K Units) by Application (2027–2032)
Table 62. Global Treatment for Accelerated-Phase CML Sales Market Share by Application (2021–2026)
Table 63. Global Treatment for Accelerated-Phase CML Sales Market Share by Application (2027–2032)
Table 64. Global Treatment for Accelerated-Phase CML Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Treatment for Accelerated-Phase CML Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Treatment for Accelerated-Phase CML Revenue Market Share by Application (2021–2026)
Table 67. Global Treatment for Accelerated-Phase CML Revenue Market Share by Application (2027–2032)
Table 68. Global Treatment for Accelerated-Phase CML Price (US$/Unit) by Application (2021–2026)
Table 69. Global Treatment for Accelerated-Phase CML Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Treatment for Accelerated-Phase CML Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Bristol Myers Squibb Company Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bristol Myers Squibb Treatment for Accelerated-Phase CML Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Treatment for Accelerated-Phase CML Product
Table 84. Novartis Recent Developments/Updates
Table 85. Takeda Pharmaceuticals Company Information
Table 86. Takeda Pharmaceuticals Description and Business Overview
Table 87. Takeda Pharmaceuticals Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Takeda Pharmaceuticals Treatment for Accelerated-Phase CML Product
Table 89. Takeda Pharmaceuticals Recent Developments/Updates
Table 90. Apotex Company Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Apotex Treatment for Accelerated-Phase CML Product
Table 94. Apotex Recent Developments/Updates
Table 95. Dr. Reddy's Laboratories Company Information
Table 96. Dr. Reddy's Laboratories Description and Business Overview
Table 97. Dr. Reddy's Laboratories Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Dr. Reddy's Laboratories Treatment for Accelerated-Phase CML Product
Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
Table 100. Chia Tai Tianqing Pharmaceutical Company Information
Table 101. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 102. Chia Tai Tianqing Pharmaceutical Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Chia Tai Tianqing Pharmaceutical Treatment for Accelerated-Phase CML Product
Table 104. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Qilu Pharmaceutical Treatment for Accelerated-Phase CML Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. CSPC Ouyi Pharmaceutical Company Information
Table 111. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 112. CSPC Ouyi Pharmaceutical Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CSPC Ouyi Pharmaceutical Treatment for Accelerated-Phase CML Product
Table 114. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 115. Lunan Pharmaceutical Company Information
Table 116. Lunan Pharmaceutical Description and Business Overview
Table 117. Lunan Pharmaceutical Treatment for Accelerated-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lunan Pharmaceutical Treatment for Accelerated-Phase CML Product
Table 119. Lunan Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Treatment for Accelerated-Phase CML Distributors List
Table 123. Treatment for Accelerated-Phase CML Customers List
Table 124. Treatment for Accelerated-Phase CML Market Trends
Table 125. Treatment for Accelerated-Phase CML Market Drivers
Table 126. Treatment for Accelerated-Phase CML Market Challenges
Table 127. Treatment for Accelerated-Phase CML Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment for Accelerated-Phase CML
Figure 2. Global Treatment for Accelerated-Phase CML Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Treatment for Accelerated-Phase CML Market Share by Type: 2025 & 2032
Figure 4. Tyrosine Kinase Inhibitors Product Picture
Figure 5. Allogeneic Stem Cell Transplantation Product Picture
Figure 6. Others Product Picture
Figure 7. Global Treatment for Accelerated-Phase CML Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Treatment for Accelerated-Phase CML Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Treatment for Accelerated-Phase CML Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Treatment for Accelerated-Phase CML Market Size (US$ Million), 2021–2032
Figure 14. Global Treatment for Accelerated-Phase CML Sales (K Units), 2021–2032
Figure 15. Global Treatment for Accelerated-Phase CML Average Price (US$/Unit), 2021–2032
Figure 16. Treatment for Accelerated-Phase CML Report Years Considered
Figure 17. Treatment for Accelerated-Phase CML Sales Share by Manufacturers in 2025
Figure 18. Global Treatment for Accelerated-Phase CML Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Treatment for Accelerated-Phase CML Players: Market Share by Revenue in Treatment for Accelerated-Phase CML in 2025
Figure 20. Treatment for Accelerated-Phase CML Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Treatment for Accelerated-Phase CML Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Treatment for Accelerated-Phase CML Sales Market Share by Country (2021–2032)
Figure 23. North America Treatment for Accelerated-Phase CML Revenue Market Share by Country (2021–2032)
Figure 24. United States Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Treatment for Accelerated-Phase CML Sales Market Share by Country (2021–2032)
Figure 27. Europe Treatment for Accelerated-Phase CML Revenue Market Share by Country (2021–2032)
Figure 28. Germany Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Treatment for Accelerated-Phase CML Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Treatment for Accelerated-Phase CML Revenue Market Share by Region (2021–2032)
Figure 35. China Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Treatment for Accelerated-Phase CML Sales Market Share by Country (2021–2032)
Figure 43. Latin America Treatment for Accelerated-Phase CML Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Treatment for Accelerated-Phase CML Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Treatment for Accelerated-Phase CML Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Treatment for Accelerated-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Treatment for Accelerated-Phase CML by Type (2021–2032)
Figure 54. Global Revenue Market Share of Treatment for Accelerated-Phase CML by Type (2021–2032)
Figure 55. Global Treatment for Accelerated-Phase CML Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Treatment for Accelerated-Phase CML by Application (2021–2032)
Figure 57. Global Revenue Market Share of Treatment for Accelerated-Phase CML by Application (2021–2032)
Figure 58. Global Treatment for Accelerated-Phase CML Price (US$/Unit) by Application (2021–2032)
Figure 59. Treatment for Accelerated-Phase CML Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
